Liftstream is an executive search recruitment company in the life sciences sector
Kuros Biosurgery Closes Round at CHF 20m
Kuros Biosurgery AG, a biotechnology company developing novel biomaterials and bioactive-biomaterial combination products and focused in therapeutic areas covering sealants and orthobiologics, today announces that it has raised an additional CHF 5 million in a fully subscribed second closing of its financing round. The CHF 5 million was raised from a group of non-disclosed new and existing investors and brings the total raised in the round to CHF 20 million.
Roche announces acquisition of InterMune
Authored by James Sheppard
Novartis and Google collaborate to develop ‘Smart Contact Lenses’
Authored by James Sheppard
Novimmune sees immunotherapy and orphan focus attract new capital
Authored by Karl Simpson
ADC Therapeutics executives on fast track with funding and partners
Authored by James Sheppard
Shire expands rare disease reach with Viropharma Purchase
Authored by James Sheppard
Roche Returns to Antibiotics with Polyphor Deal
Authored by James Sheppard
PAH franchise and cost cutting prevent Actelion from listing further
Authored by Karl Simpson
Polyphor begin Board succession with appointment of pharmaceutical Senior Executives
Authored by Karl Simpson
GSK Expands Vaccines Capabilities with Okairos Purchase
Authored by James Sheppard